Olivier Loeillot insider trades
Open-market stock purchases and sales by Olivier Loeillot, Chief Executive Officer at Repligen Corp, from SEC Form 4 filings since Oct 2, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 21, 2026 | RGEN Repligen Corp | Sold | $536K |
| Mar 5, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| Mar 5, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| Mar 2, 2026 | RGEN Repligen Corp | Sold (not open market) | $201K |
| Feb 27, 2026 | RGEN Repligen Corp | Sold (not open market) | $44.3K |
| Nov 25, 2025 | RGEN Repligen Corp | Sold | $1.2M |
| Oct 2, 2025 | RGEN Repligen Corp | Sold (not open market) | $181K |
Companies traded
- RGEN Repligen Corp: 2 sales, last Apr 21, 2026